Merck Total Current Liabilities from 2010 to 2026
| MRK Stock | 27.83 0.87 3.23% |
Total Current Liabilities | First Reported 2010-12-31 | Previous Quarter 32.7 B | Current Value 28.7 B | Quarterly Volatility 2.4 B |
Check Merck CDR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merck CDR's main balance sheet or income statement drivers, such as Tax Provision of 2.5 B, Interest Income of 1 B or Selling General Administrative of 11.5 B, as well as many indicators such as . Merck financial statements analysis is a perfect complement when working with Merck CDR Valuation or Volatility modules.
Merck | Total Current Liabilities |
Evaluating Merck CDR's Total Current Liabilities across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Merck CDR's fundamental strength.
Latest Merck CDR's Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of Merck CDR over the last few years. Total Current Liabilities is an item on Merck CDR balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Merck CDR are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Merck CDR's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Merck CDR's overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
Merck Total Current Liabilities Regression Statistics
| Arithmetic Mean | 25,331,378,431 | |
| Geometric Mean | 25,237,528,054 | |
| Coefficient Of Variation | 9.40 | |
| Mean Deviation | 1,670,696,425 | |
| Median | 24,239,000,000 | |
| Standard Deviation | 2,381,923,759 | |
| Sample Variance | 5673560.8T | |
| Range | 8.4B | |
| R-Value | 0.66 | |
| Mean Square Error | 3400026.8T | |
| R-Squared | 0.44 | |
| Significance | 0 | |
| Slope | 312,236,438 | |
| Total Sum of Squares | 90776972.7T |
Merck Total Current Liabilities History
About Merck CDR Financial Statements
Merck CDR investors utilize fundamental indicators, such as Total Current Liabilities, to predict how Merck Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 32.7 B | 28.7 B |
Pair Trading with Merck CDR
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Merck CDR position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merck CDR will appreciate offsetting losses from the drop in the long position's value.Moving together with Merck Stock
Moving against Merck Stock
The ability to find closely correlated positions to Merck CDR could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Merck CDR when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Merck CDR - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Merck CDR to buy it.
The correlation of Merck CDR is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Merck CDR moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Merck CDR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Merck CDR can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Merck Stock
Merck CDR financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck CDR security.